Beating Biologic Resistance: A New Nanovaccine Approach

Imagine you're taking medicine that your body refuses to accept because it mistakenly thinks it's an invader. This is a big problem in biologic therapies, where medicines like enzymes and gene therapies can trigger unwanted immune responses, making them less effective. Scientists are tackling this issue with a smart little tool called a lipid-rapamycin nanovaccine. This tiny powerhouse helps your immune system chill out and accept these medicines. In tests, it worked with different medicines like pegylated uricase and AAV8 gene therapy.

It even allowed reusing these medicines after a break, boosting their effects. The nanovaccine also caused helpful immune cells in the liver to change in a way that helps keep the body's immune balance. This means it can safely tune down the immune response to these medicines without messing up your body's ability to fight off infections or cancers. So, this nanovaccine could be a game-changer in making biologic therapies work better for longer.

Actions